Immunological investigation of the hepatic tissue from infants with biliary atresia

Pediatric Surgery International

Volumn 25, Issue 2, 2009, Pages 157-162

  Baba, Haruna ^a   Ohtsuka, Yoshikazu ^a   Fujii, Tohru ^a   Haruna, Hidenori ^a   Nagata, Satoru ^a   Kobayashi, Hiroyuki ^a   Yamataka, Atsuyuki ^a   Shimizu, Toshiaki ^a   Miyano, Takeshi ^a   Yamashiro, Yuichiro ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biliary atresia; CC chemokines; Inhibitor of metalloproteinase; Liver fibrosis; Metalloproteinase

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CYTOKINE; GELATINASE B; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; BILE DUCT ATRESIA; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGY; LIVER; LIVER FIBROSIS; MALE; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; TH1 CELL; TH2 CELL;

BILIARY ATRESIA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; RECEPTORS, CCR4; RECEPTORS, CCR5; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 64949191420     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-008-2311-9     Document Type: Article

References (31)

1. T Okazaki H Kobayashi A Yamataka 1999 Long-term postsurgical outcome of biliary atresia J Pediatr Surg 34 312 315 10.1016/S0022-3468(99)90198-7
2. CC Huang JH Chuang MH Chou 2005 Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis Mod Pathol 18 941 950 10.1038/modpathol.3800374
3. WC Parks CL Wilson YS Lopez-Boado 2004 Matrix metalloproteinases as modulators of inflammation and innate immunity Nat Rev Immunol 4 617 629 10.1038/nri1418
4. AE Kossakowska DR Edwards SS Lee 1998 Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis Am J Pathol 153 1895 1902
5. YY Li AM Feldman Y Sun 1998 Differential expression of tissue inhibitors of metalloproteinases in the failing human heart Circulation 98 1728 1734
6. QH Nie GR Duan XD Luo 2004 Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis World J Gastroenterol 10 86 90
7. JA Uria AA Ferrando G Velasco 1994 Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family Cancer Res 54 2091 2094
8. Y Okada H Nagase ED Harris 1986 A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization J Biol Chem 261 14245 14255
9. K Suzuki JJ Enghild T Morodomi 1990 Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin) Biochemistry 29 10261 10270 10.1021/bi00496a016
10. H Nagase JJ Enghild K Suzuki 1990 Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate Biochemistry 29 5783 5789 10.1021/bi00476a020
11. K Imai Y Yokohama I Nakanishi 1995 Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties J Biol Chem 270 6691 6697 10.1074/jbc.270.12.6691
12. V Knauper SM Wilhelm PK Seperack 1993 Direct activation of human neutrophil procollagenase by recombinant stromelysin Biochem J 295 581 586
13. Y Ogata JJ Enghild H Nagase 1992 Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9 J Biol Chem 267 3581 3584
14. G Murphy H Stanton S Cowell 1999 Mechanisms for pro matrix metalloproteinase activation Acta Pathol Microbiol Scand Suppl 107 38 44
15. Y Itoh H Nagase 1995 Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of metalloproteinase 9 (progelatinase B) by human neutrophil elastase J Biol Chem 270 16518 16521 10.1074/jbc.270.28.16518
16. SC Robinson KA Scott FR Balkwill 2002 Chemokine stimulation of matrix metalloproteinase-9 requires endogenous TNF-α Eur J Immunol 32 404 412 doi:10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X
17. KA Stormes CA Lemken JV Lepre 2005 Inhibition of metasis by inhibition of tumor-derived CCL5 Breast Cancer Res Treat 89 209 212 10.1007/s10549-004-5328-3
18. I Kamal B Amelia B Leonardo 1995 Histological grading and staging of chronic hepatitis J Hepatol 22 696 699 10.1016/0168-8278(95)80226-6
19. CS Hsieh JH Chuang CC Haung 2005 Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis J Pediatr Surg 40 1568 1573 10.1016/j.jpedsurg.2005.06.028
20. B Vaillant MG Chiaramonte AW Cheever 2001 Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases J Immunol 167 7017 7026
21. AE Kossakowska DR Edwards SS Lee 1998 Altered balance between matrix metalloproteinase and their inhibitors in experimental biliary fibrosis Am J Pathol 153 6 1895 1902
22. E Roeb E Purucker B Breuer 1997 TIMP expression in toxic and cholestatic liver injury in rat J Hepatol 27 535 544 10.1016/S0168-8278(97)80359-5
23. R Lichtinghagen D Michels CI Haberkorn 2001 Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C J Hepatol 34 237 247 10.1016/S0168-8278(00)00037-4
24. Y Murawaki Y Ikuta H Kawasaki 1999 Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay with chronic liver disease in comparison with serum TIMP-1 Clin Chim Acta 281 109 120 10.1016/S0009-8981(98) 00215-0
25. B Zhang Y Ohtsuka T Fujii 2005 Immunological development of preterm infants in early infancy Clin Exp Immunol 140 92 96 10.1111/j.1365-2249.2005. 02741.x
26. GA McQuibban 2002 Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory proteins in vivo Blood 100 1160 1167
27. Q Yu I Stamenkovic 2000 Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis Genes Dev 14 163 176
28. S Maeda DD Dean R Gomez 2002 The first stage of transforming growth factor β1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3) Calcif Tissue Int 70 54 65 10.1007/s002230010032
29. MA Karsdal 2002 Matrix metalloproteinase-dependent activation of latent transforming growth factor β1 controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis J Biol Chem 277 44061 44067 10.1074/jbc.M207205200
30. U Schonbeck F Mach P Libby 1998 Generation of biologically active IL-1β by matrix metalloproteinase: a novel caspase-1-independent pathway of IL-1β processing J Immunol 161 3340 3346
31. H Kobayashi N Hayashi K Hayashi 2005 Connective tissue growth factor and progressive fibrosis in biliary atresia Pediatr Surg Int 21 12 16 10.1007/s00383-004-1254-z